Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study

Background: Defining clinical and subclinical progression in multiple sclerosis (MS) is challenging. Patient history, expanded disability status scale (EDSS), and magnetic resonance imaging (MRI) all have shortcomings and may underestimate disease dynamics. Emerging serum biomarkers such as glial fi...

Full description

Bibliographic Details
Main Authors:	Ahmed Abdelhak, Andre Huss, Alexander Stahmann, Makbule Senel, Markus Krumbholz, Markus C. Kowarik, Joachim Havla, Tania Kümpfel, Ingo Kleiter, Isabella Wüstinger, Uwe K. Zettl, Margit Schwartz, Romy Roesler, Tim Friede, Albert C. Ludolph, Ulf Ziemann, Hayrettin Tumani
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	Contemporary Clinical Trials Communications
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451865420300582

Similar Items

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
by: Ahmed Abdelhak, et al.
Published: (2024-02-01)

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
by: André Huss, et al.
Published: (2020-07-01)

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
by: André Huss, et al.
Published: (2020-08-01)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
by: Makbule Senel, et al.
Published: (2019-03-01)

Human immunodeficiency virus and multiple sclerosis: a review of the literature
by: Maria-Ioanna Stefanou, et al.
Published: (2019-08-01)

Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases
by: Johannes Dorst, et al.
Published: (2020-09-01)

Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
by: Makbule Senel, et al.
Published: (2014-01-01)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
by: Tilman Robinson, et al.
Published: (2020-11-01)

CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study
by: Deborah Katharina Erhart, et al.
Published: (2023-12-01)

Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis
by: Jonathan A. Gernert, et al.
Published: (2023-08-01)

Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS Infections
by: Makbule Senel, et al.
Published: (2020-09-01)

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
by: Badrieh Fazeli, et al.
Published: (2023-04-01)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
by: Ahmed Abdelhak, et al.
Published: (2017-05-01)

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
by: Ahmed Abdelhak, et al.
Published: (2019-03-01)

Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies
by: Alexander J. Davies, et al.
Published: (2020-06-01)

Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
by: Joachim Havla, et al.
Published: (2021-05-01)

Recurrent Acute Disseminated Encephalomyelitis (ADEM) after COVID-19-vaccination and after subsequent COVID-19-infection: A case report (part II)
by: Khouloud Poli, et al.
Published: (2023-03-01)

Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial
by: Johannes Dorst, et al.
Published: (2019-11-01)

Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease
by: André Huss, et al.
Published: (2022-08-01)

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).
by: Johannes Brettschneider, et al.
Published: (2010-01-01)

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
by: Hela-Felicitas Petereit, et al.
Published: (2021-06-01)

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.
by: Ahmed Abdelhak, et al.
Published: (2017-01-01)

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
by: Christoph Kessler, et al.
Published: (2022-11-01)

Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases – a retrospective cross-sectional study
by: Felix Brauchle, et al.
Published: (2023-06-01)

The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis
by: Massimiliano Castellazzi, et al.
Published: (2022-06-01)

Computed tomography perfusion imaging-guided intravenous thrombolysis in acute minor ischemic stroke
by: Jennifer Sartor-Pfeiffer, et al.
Published: (2023-11-01)

Neurochemical Biomarkers in patients with COVID-19
by: Hayrettin Tumani
Published: (2023-04-01)

Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
by: C L Kemmerer, et al.
Published: (2020-01-01)

Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
by: Petra Steinacker, et al.
Published: (2011-01-01)

Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study
by: Antonios Bayas, et al.
Published: (2024-03-01)

The TRACK-MS Test Battery: A Very Brief Tool to Track Multiple Sclerosis-Related Cognitive Impairment
by: Daniela Taranu, et al.
Published: (2022-11-01)

Serum GFAP as a biomarker for disease severity in multiple sclerosis
by: A. Abdelhak, et al.
Published: (2018-10-01)

Cladribine treatment specifically affects peripheral blood memory B cell clones and clonal expansion in multiple sclerosis patients
by: Christoph Ruschil, et al.
Published: (2023-03-01)

Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?
by: Havla J, et al.
Published: (2013-10-01)

Clinical-Radiological Mismatch in Multiple Sclerosis Patients during Acute Relapse: Discrepancy between Clinical Symptoms and Active, Topographically Fitting MRI Lesions
by: Jutta Dünschede, et al.
Published: (2023-01-01)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
by: Veronika Klose, et al.
Published: (2023-05-01)

Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses
by: Christoph Ruschil, et al.
Published: (2020-12-01)

Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology
by: Nagiua Cuomo-Haymour, et al.
Published: (2022-01-01)

Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression—A Case Report
by: Sarah Jesse, et al.
Published: (2021-02-01)

Uncovering historical roots of nature-based solutions: Christian Ludwig Krause's approaches to restoring degraded land in an 18th-century European landscape
by: Ingo Kowarik
Published: (2023-12-01)